Clinical Drug Experience Knowledgebase

abacavir (ziagen) (3 trials)

albendazole (Albenza) (1 trial)

amprenavir (agenerase) (1 trial)

azithromycin (zithromax) (1 trial)

cabotegravir (Vocabria) (1 trial)

cefotaxime (claforan) (1 trial)

darunavir (prezista) (2 trials)

dolutegravir (tivicay) (4 trials)

efavirenz (sustiva) (2 trials)

elvitegravir (vitekta) (1 trial)

emtricitabine (emtriva) (3 trials)

fluconazole (diflucan) (1 trial)

gentamicin (garamycin) (1 trial)

indinavir (crixivan) (1 trial)

isoniazid (nydrazid) (1 trial)

lamivudine (epivir) (4 trials)

lopinavir (Kaletra) (2 trials)

meropenem (merrem) (2 trials)

nelfinavir (viracept) (1 trial)

nevirapine (viramune) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

raltegravir (isentress) (1 trial)

rilpivirine (edurant) (1 trial)

ritonavir (Norvir) (3 trials)

saquinavir (invirase) (1 trial)

stavudine (zerit) (1 trial)

tenofovir (viread) (2 trials)

valganciclovir (Valcyte) (1 trial)

zidovudine (retrovir) (1 trial)

fostemsavir (Rukobia) (1 trial)

tenofovir alafenamide (genvoya) (1 trial)

vancomycin (Vancocin) (1 trial)

hivis dna vaccine (1 trial)

hpv 16/18 vaccine (Cervarix) (1 trial)

mva-cmdr (1 trial)